Cargando…

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors

INTRODUCTION: Hepatic steatosis (HS) negatively impacts transplant outcomes in living liver donors. To date, liver biopsy is preferred for HS evaluation. This study aims to evaluate the measurement of controlled attenuation parameter (CAP) as a diagnostic tool of HS in living liver donors. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broering, Dieter, Shawkat, Mohamed, Albenmousa, Ali, Abaalkhail, Faisal, Alabbad, Saleh, Al-Hamoudi, Waleed, Alghamdi, Saad, Alqahthani, Saleh, Jaafari, Ahmad, Troisi, Roberto, Bzeizi, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118256/ https://www.ncbi.nlm.nih.gov/pubmed/33984017 http://dx.doi.org/10.1371/journal.pone.0251487

Ejemplares similares

Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
por: Bzeizi, Khalid Ibrahim, et al.
Publicado: (2021)

Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Diabetes mellitus is not associated with worse short term outcome in patients older than 65 years old post-liver transplantation
por: Alghamdi, Saad, et al.
Publicado: (2023)

Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Bzeizi, Khalid I., et al.
Publicado: (2021)

Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
por: Bzeizi, Khalid I., et al.
Publicado: (2022)

The first two cases of living donor liver transplantation using dual grafts in Saudi Arabia
por: Zidan, Ahmed, et al.
Publicado: (2019)

First Experience in Living Liver Donation From Donors With Sickle Cell Trait
por: Schulze, Maren, et al.
Publicado: (2022)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia
por: Al-Judaibi, Bandar, et al.
Publicado: (2022)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
por: Bzeizi, Khalid, et al.
Publicado: (2021)

Invasive Mucormycosis in a Patient With Liver Cirrhosis: Case Report and Review of the Literature
por: Elsiesy, Hussien, et al.
Publicado: (2013)

SASLT Practice Guidelines for the Management of Hepatitis B Virus
por: Abaalkhail, Faisal, et al.
Publicado: (2014)

Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population
por: Alswat, Khalid A., et al.
Publicado: (2013)

Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015
por: Alghamdi, Ibrahim G, et al.
Publicado: (2021)

Saudi Association for the Study of Liver Diseases and Transplantation position statement on liver transplantation during the COVID-19 pandemic
por: Al-Judaibi, Bandar, et al.
Publicado: (2020)

First fully laparoscopic donor hepatectomy for pediatric liver transplantation using the indocyanine green near-infrared fluorescence imaging in the Middle East: a case report
por: Troisi, Robert Ivan, et al.
Publicado: (2014)

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

Hyponatremia as the Initial Presentation of Cryptococcal Meningitis After Liver Transplantation
por: Mansoor, Saad, et al.
Publicado: (2015)

Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
por: Alghamdi, Saad, et al.
Publicado: (2023)

Controlled attenuation parameter measured using transient elastography for the noninvasive assessment of macrovesicular steatosis in potential living liver donors
por: Lee, Sunyoung, et al.
Publicado: (2022)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
por: Alswat, Khalid, et al.
Publicado: (2021)

Gastropleural fistula after single anastomosis gastric bypass. A case report and review of the literature
por: Al-shurafa, Haider, et al.
Publicado: (2017)

Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
por: Al-hamoudi, Waleed, et al.
Publicado: (2020)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Liver abscess presentation and management in Saudi Arabia and the United Kingdom
por: Albenmousa, Ali, et al.
Publicado: (2011)

HCV genotypes among 1013 Saudi nationals: a multicenter study
por: Al Traif, Ibrahim, et al.
Publicado: (2013)

Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?
por: Sirli, Roxana, et al.
Publicado: (2021)

The Saudi Association for the Study of Liver Diseases and Transplantation clinical practice guidelines for management of autoimmune hepatitis
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees
por: Kim, Ja Kyung, et al.
Publicado: (2015)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
por: Ferraioli, Giovanna, et al.
Publicado: (2017)

Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
por: Ferraioli, Giovanna
Publicado: (2021)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
por: Alswat, Khalid, et al.
Publicado: (2018)

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbklqm0dr0hb8ntlks1pemsk16